Schimmelpennink Evert B. has filed 15 insider transactions across 3 companies since March 2024.
Most recent transaction: a purchase of 28089 shares of LENZ Therapeutics, Inc. ($LENZ) on March 27, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | P | Common Stock | 28089 | $8.95 | 77,289.0000 | 31,289,969 | 57.09% | 0.09% |
| Jan. 2, 2026 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 358100 | $0.00 | 358,100.0000 | 31,289,969 | 9999.99% | 1.14% |
| Nov. 20, 2025 | iBio, Inc. | $IBIO | Schimmelpennink Evert B. | Director | A | Stock Option (right to buy) | 13500 | $0.00 | 13,500.0000 | 52,981,000 | 9999.99% | 0.03% |
| June 26, 2025 | Contineum Therapeutics, Inc. | $CTNM | Schimmelpennink Evert B. | Director | A | Stock Option (right to buy) | 14750 | $0.00 | 14,750.0000 | 19,352,859 | 9999.99% | 0.08% |
| March 7, 2025 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | M | Common Stock | 4200 | $1.04 | 49,200.0000 | 0 | 9.33% | 0.00% |
| March 7, 2025 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | M | Stock Option (right to buy) | 4200 | $0.00 | 337,906.0000 | 0 | 1.23% | 0.00% |
| Jan. 9, 2025 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 279100 | $0.00 | 279,100.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | iBio, Inc. | $IBIO | Schimmelpennink Evert B. | Director | A | Stock Option (right to buy) | 18900 | $0.00 | 18,900.0000 | 8,633,000 | 9999.99% | 0.22% |
| July 22, 2024 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | M | Common Stock | 45000 | $1.04 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2024 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | M | Stock Option (right to buy) | 45000 | $0.00 | 342,106.0000 | 0 | 11.62% | 0.00% |
| May 24, 2024 | Contineum Therapeutics, Inc. | $CTNM | Schimmelpennink Evert B. | Director | A | Stock Option (right to buy) | 29500 | $0.00 | 29,500.0000 | 2,308,972 | 9999.99% | 1.28% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 475000 | $0.00 | 475,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 315864 | $0.00 | 315,864.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 82723 | $0.00 | 82,723.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | LENZ Therapeutics, Inc. | $LENZ | Schimmelpennink Evert B. | President, CEO and Secretary | A | Stock Option (right to buy) | 387106 | $0.00 | 387,106.0000 | 0 | 9999.99% | 0.00% |